KR20190102463A - Hard-type Low calory Mayonnaise conposition for Intestinal regulation comprising lactic acid bacteria and preparation method thereof - Google Patents

Hard-type Low calory Mayonnaise conposition for Intestinal regulation comprising lactic acid bacteria and preparation method thereof Download PDF

Info

Publication number
KR20190102463A
KR20190102463A KR1020180022879A KR20180022879A KR20190102463A KR 20190102463 A KR20190102463 A KR 20190102463A KR 1020180022879 A KR1020180022879 A KR 1020180022879A KR 20180022879 A KR20180022879 A KR 20180022879A KR 20190102463 A KR20190102463 A KR 20190102463A
Authority
KR
South Korea
Prior art keywords
mayonnaise
lactic acid
acid bacteria
present
hard
Prior art date
Application number
KR1020180022879A
Other languages
Korean (ko)
Other versions
KR102417609B1 (en
Inventor
주재원
박정호
Original Assignee
농업회사법인 케이원(주)
박정호
주재원
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 농업회사법인 케이원(주), 박정호, 주재원 filed Critical 농업회사법인 케이원(주)
Priority to KR1020180022879A priority Critical patent/KR102417609B1/en
Priority to PCT/KR2018/002453 priority patent/WO2019164043A1/en
Publication of KR20190102463A publication Critical patent/KR20190102463A/en
Application granted granted Critical
Publication of KR102417609B1 publication Critical patent/KR102417609B1/en

Links

Images

Classifications

    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23LFOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L27/00Spices; Flavouring agents or condiments; Artificial sweetening agents; Table salts; Dietetic salt substitutes; Preparation or treatment thereof
    • A23L27/60Salad dressings; Mayonnaise; Ketchup
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23LFOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L3/00Preservation of foods or foodstuffs, in general, e.g. pasteurising, sterilising, specially adapted for foods or foodstuffs
    • A23L3/40Preservation of foods or foodstuffs, in general, e.g. pasteurising, sterilising, specially adapted for foods or foodstuffs by drying or kilning; Subsequent reconstitution
    • A23L3/44Freeze-drying
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23LFOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/135Bacteria or derivatives thereof, e.g. probiotics
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23LFOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/20Reducing nutritive value; Dietetic products with reduced nutritive value
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23LFOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/20Reducing nutritive value; Dietetic products with reduced nutritive value
    • A23L33/21Addition of substantially indigestible substances, e.g. dietary fibres
    • A23L33/28Substances of animal origin, e.g. gelatin or collagen
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23PSHAPING OR WORKING OF FOODSTUFFS, NOT FULLY COVERED BY A SINGLE OTHER SUBCLASS
    • A23P10/00Shaping or working of foodstuffs characterised by the products
    • A23P10/20Agglomerating; Granulating; Tabletting
    • A23P10/28Tabletting; Making food bars by compression of a dry powdered mixture
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23PSHAPING OR WORKING OF FOODSTUFFS, NOT FULLY COVERED BY A SINGLE OTHER SUBCLASS
    • A23P10/00Shaping or working of foodstuffs characterised by the products
    • A23P10/30Encapsulation of particles, e.g. foodstuff additives
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23VINDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2002/00Food compositions, function of food ingredients or processes for food or foodstuffs
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23VINDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2200/00Function of food ingredients
    • A23V2200/12Replacer
    • A23V2200/124Fat replacer
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23VINDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2200/00Function of food ingredients
    • A23V2200/14Mouthfeel improving agent
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23VINDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2200/00Function of food ingredients
    • A23V2200/30Foods, ingredients or supplements having a functional effect on health
    • A23V2200/32Foods, ingredients or supplements having a functional effect on health having an effect on the health of the digestive tract
    • A23V2200/3204Probiotics, living bacteria to be ingested for action in the digestive tract
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23VINDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2200/00Function of food ingredients
    • A23V2200/30Foods, ingredients or supplements having a functional effect on health
    • A23V2200/332Promoters of weight control and weight loss
    • A23V2200/3324Low fat - reduced fat content
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23VINDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2250/00Food ingredients
    • A23V2250/50Polysaccharides, gums
    • A23V2250/51Polysaccharide
    • A23V2250/5108Cellulose
    • A23V2250/51086Hydroxyalkyl cellulose

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Food Science & Technology (AREA)
  • Polymers & Plastics (AREA)
  • Health & Medical Sciences (AREA)
  • Nutrition Science (AREA)
  • Mycology (AREA)
  • Zoology (AREA)
  • Seasonings (AREA)

Abstract

The present invention relates to a low-calorie mayonnaise composition comprising 25 to 30 wt% of olive oil, 20 wt% of an MC aqueous solution, and 12 to 15 wt% of egg yolk and, more specifically, to a new hard-type low-calorie mayonnaise with an intestinal regulatory function, which additionally comprises an equivalence ratio (w/w) tablet of HPMCP and P. acidilactici lactic acid bacterial strain is added, thereby having excellent chewability.

Description

유산균이 함유된 정장 기능성 저열량 하드타입 마요네즈 및 그 제조방법 {Hard-type Low calory Mayonnaise conposition for Intestinal regulation comprising lactic acid bacteria and preparation method thereof}Hard-type low calory mayonnaise conposition for Intestinal regulation comprising lactic acid bacteria and preparation method

본 발명은 유산균이 함유된 정장기능성 저열량 씹힘성이 있는 하드 타입 (hard type) 마요네즈 및 그 제조방법에 관한 것이다.The present invention relates to a hard type mayonnaise containing a lactic acid bacterium and a low-functional chemo-functional low calorie chewability and a method of manufacturing the same.

정장작용은 인체 장내 유해균 증식을 억제하거나 장의 연동운동을 촉진시켜 변비나 설사를 예방 또는 개선하는 것을 말한다. 정장작용에 유익한 식품은 유산균이 함유된 요구르트 또는 식이섬유가 풍부한 채소를 들 수 있다.Intestinal action refers to preventing or improving constipation or diarrhea by inhibiting the growth of harmful bacteria in the intestine or promoting intestinal peristalsis. Foods that are beneficial for intestinal action include yogurt containing lactic acid bacteria or vegetables rich in dietary fiber.

마요네즈는 지방함량이 80% 이상 함유된 고지방식품으로 계란 또는 난황성분인 레시틴(lecitin)이나 리포단백질(lipoprotein)이 유화력을 가지고 있어서 지방성분을 포접하여 물에 잘 분산되도록 제조된 수중유적형(o/w)의 에멀젼 제품이다.Mayonnaise is a high-fat food containing more than 80% fat. Oil-based oil-based oil or egg yolk ingredient (lecitin) or lipoprotein (lipoprotein) has emulsifying power. / w) emulsion product.

최근 지방섭취의 증가로 인한 비만, 고혈압, 심장질환 등 각종 성인병의 이환율이 급격히 증가일로에 있으며 이와 관련하여 고지방식이가 원인이 된 성인병으로 인하여 지방섭취의 감소, 저열량 및 저지방식품의 요구가 현저히 증대되었다. 이에 따라 마요네즈와 같은 기존식품의 제조공정에서 대두유 또는 올리브유 등 지방성분 원료를 대체할 수 있는 방법은 지방함량을 낮추고 열량이 감소된 마요네즈를 개발할 수 있다는 장점이 있다. Recently, the morbidity rate of various adult diseases such as obesity, hypertension and heart disease due to the increase of fat intake is increasing rapidly. In this connection, the reduction of fat intake, low calorie and low-fat foods is remarkably demanded due to the adult disease caused by high fat diet. Increased. Accordingly, the method of replacing fatty ingredients such as soybean oil or olive oil in the existing food manufacturing process such as mayonnaise has the advantage of lowering fat content and developing mayonnaise with reduced calories.

마요네즈는 최초 프랑스에서 개발된 샐러드용 소스의 일종으로 초기에는 계란의 난황, 샐러드유에 식초, 소금, 설탕이 주요 원료성분이었다.Mayonnaise is a kind of salad sauce originally developed in France. Initially, egg yolk, salad oil, vinegar, salt and sugar were the main ingredients.

계란은 완전식품으로 특히 마요네즈 제조시에는 일반적으로 유화제로서 사용된다. 난황에는 평균 210mg의 콜레스테롤이 함유되어 있고 따라서 계란에서 콜레스테롤 성분을 제거하거나 난백만을 사용하여 마요네즈를 제조하려는 시도가 있었다(국내등록특허 제288012 및 제217199호). 그러나, 알러젠 물질도 완전히 제거할 수도 없으며 난백만으로는 유화안정도와 보형성 확보가 곤란하다는 단점이 있었다.Eggs are complete foods and are generally used as emulsifiers, especially in the preparation of mayonnaise. Egg yolk contains an average of 210 mg of cholesterol, and therefore, attempts have been made to remove cholesterol from eggs or to prepare mayonnaise using egg yolk (Korean Patent Nos. 288012 and 217199). However, allergens cannot be completely removed, and it is difficult to secure emulsification stability and shape retaining properties with egg mills.

따라서, 본 발명자들은 계란난황을 유화제의 주재로 사용함에 있어서 유지함량과 콜레스테롤의 함량을 낮추어 열량도 저하시키는 저콜레스테롤 저열량 마요네즈를 예의 연구하고자 하였다. 또한, 본 발명자들은 유산균을 효과적으로 포접시켜 강산 조건인 위장관을 통과시킨후 소장 내로 침투시켜 정장작용을 증대시키는 방법에 대하여도 예의 연구하고 나아가 씹힘성이 우수한 신규의 마요네즈를 제공하는데 예의 노력한 결과 본 발명을 완성하기에 이르렀다.Therefore, the present inventors sought to study the low cholesterol low calorie mayonnaise to lower the calorie content by lowering the fat content and cholesterol in using egg yolk as the emulsifier. In addition, the present inventors earnestly research on a method of effectively encapsulating lactic acid bacteria to pass the gastrointestinal tract, which is a strong acid condition, and then penetrate into the small intestine to increase intestinal action. It was completed.

따라서 본 발명의 목적은 유지함량을 낮추고 동시에 정장작용과 씹힘성이 구비된 신규한 하드 타입 제형의 저열량 마요네즈 조성물을 제공하는 데 있다.Accordingly, it is an object of the present invention to provide a low calorie mayonnaise composition of a novel hard type formulation having low maintenance content and at the same time having a formal action and chewability.

본 발명의 다른 목적은 상기 신규한 하드 타입 제형의 저열량 정장 기능성 마요네즈를 제조하는 방법을 제공한다.Another object of the present invention is to provide a method for preparing low calorie formal functional mayonnaise of the novel hard type formulation.

본 발명의 상기 목적은 마요네즈 조성물 총중량을 기준으로 식물성 유지를 30중량% 이하로 감소시킴과 동시에 유산균을 효과적으로 포접시킬 수 있는 유기화합물(polymer)를 선택함으로써 달성된다.The above object of the present invention is achieved by selecting an organic polymer capable of effectively encapsulating lactic acid bacteria while at the same time reducing the vegetable fat or oil based on the total weight of the mayonnaise composition.

본 발명의 상기 목적은 위장관 pH 2~5 정도에서도 분자구조의 변형이 없는 내산성인 폴리머(polymer)를 선택함으로써 달성할 수 있다.The object of the present invention can be achieved by selecting an acid-resistant polymer (polymer) without modification of the molecular structure even in the gastrointestinal pH 2 ~ 5 degree.

또, 본 발명의 상기 목적은 유산균 (probiotics) 중에서 동결건조 (freeze-drying)하는 경우 저항성이 작은(smaller) cell size 이면서도 구형 세포(spherical cells)를 선택함으로써 달성된다.In addition, the above object of the present invention is achieved by selecting spherical cells with small cell size when freeze-drying among probiotics.

이밖에도 채소류에 사용되는 저열량 마요네즈로 사용되지 위하여는 유산균의 생태환경(echosystem)에 있어서 내산성 균주(pH-sensitive microbe)를 선택함으로써 달성된다.In addition, in order to be used as a low calorie mayonnaise used in vegetables is achieved by selecting a acid-resistant strain (pH-sensitive microbe) in the ecosystem (echosystem) of lactic acid bacteria.

본 발명에 따르면 pH 1.5 이하의 위장관액(gastric fluids)에서 불용성이지만 소장(small intestine) 상부 pH 5.5 이하에서는 신속히 용해되는 장용성 기제의 폴리머로서 히드록시프로필 메틸셀룰로오스 프탈레이트(HPMCP) 파우더가 가장 바람직하다.According to the present invention, hydroxypropyl methylcellulose phthalate (HPMCP) powder is most preferred as an enteric based polymer which is insoluble in gastric fluids of pH 1.5 or less but rapidly dissolves in pH 5.5 or lower of the small intestine.

한편, 본 발명 마요네즈를 구성하는 식물성 유지방의 대체용 부형제로는 히드록시프로필 메틸셀룰로오스(HPMC)또는 메틸셀룰로오스(MC)가 바람직하다. 그러나, 본 발명에 따른 저지방 마요네즈의 보형성을 유지할 수 있는 가장 바람직한 부형제는 MC이다. On the other hand, hydroxypropyl methyl cellulose (HPMC) or methyl cellulose (MC) is preferable as an excipient for replacing vegetable fats and oils constituting the mayonnaise of the present invention. However, the most preferred excipient capable of maintaining the shape retention of low fat mayonnaise according to the present invention is MC.

본 발명에 따르면, 상기 유지방대체물질로서 MC는 계란의 난황을 본 발명 마요네즈의 부형제로 사용하는 것이 가장 바람직하다.According to the present invention, as the milk fat substitute, MC is most preferably using egg yolk as an excipient of the mayonnaise of the present invention.

한편, 본 발명에 따르면 상기 HPMCP는 유산균을 포접하는데 매우 유용한 장용성 기제임이 확인되었다. 상기 HPMCP는 본 발명에서 사용하는 내산성 유산균의 포접제로서 매우 유용하다.가장 바람직하기는 내산성 유산균을 내산성 HPMCP와 2~3% 범위 내에서 중량비 3~5 KP(Kilopound) 힘으로 0.5~1.5 mm size의 극미세하게 타정하여 제조된 tablet을 첨가함으로써, 씹힘성이 우수한 신규한 마요네즈 제품을 제조할 수 있다. 상기 내산성 유산균 probiotics는 공지된 enterococci 속의 소형이며 구형 세포(small spherical cells)가 가장 바람직하다.On the other hand, according to the present invention, it was confirmed that the HPMCP is an enteric agent which is very useful for encapsulating lactic acid bacteria. The HPMCP is very useful as a clathrate for acid-resistant lactic acid bacteria used in the present invention. Most preferably, the acid-resistant lactic acid bacteria are 0.5 to 1.5 mm in size with a weight ratio of 3 to 5 KP (Kilopound) force within the range of 2 to 3% with acid-resistant HPMCP. By adding the tablets prepared by the ultra-fine tablets, new mayonnaise products with excellent chewability can be prepared. The acid resistant lactic acid bacteria probiotics are small and spherical cells of the genus known enterococci is most preferred.

본 발명에 따르면 내열성이며 내산성이 강한 Pediococcus acidlactici PAGS KCTC18229P이다.According to the present invention, the heat resistant and acid resistant Pediococcus acidlactici PAGS KCTC18229P.

또, 상기 probiotics 균주는 상기와 같이 HPMCP를 사용하여 타정한 것이거나 또는 필요한 경우 동결건조하여(freeze-dry) 사용할 수 있다. 동결건조한 probiotics 제품을 사용하는 경우에는 동결건조전 반드시 보호제(protectant) 또는 동결보존제(cryoprotectants)를 사용하여야 한다. 이는 세포 내외에 존재하는 수분 동결과정에서 세포손상(cell damage)을 초래하기 때문이다. 본 발명에 따르면 동결건조과정에서 dehydration 시 유산균 생존율을 유지시키기 위하여 탈지분유, 트레할로스, 글리세롤, 스크로스, 글루코스 등 1~2 당류 또는 덱스트란 또는 폴리에틸렌글리콜 등 복합 다당류 중에서 어느 하나가 사용될 수 있다.In addition, the probiotics strain may be used as tableted using the HPMCP as described above or, if necessary, freeze-dry. When using lyophilized probiotics products, protectants or cryoprotectants must be used before lyophilization. This is because it causes cell damage during the water freezing process existing inside and outside the cell. According to the present invention, in order to maintain lactic acid bacteria survival rate during dehydration during freeze-drying process, any one of 1-2 sugars such as skim milk powder, trehalose, glycerol, scrub, glucose, or a complex polysaccharide such as dextran or polyethylene glycol may be used.

또, 본 발명에 따르면 저열량 마요네즈의 제조시 MC는 다양한 저장 및 유통온도에서 보형성 유지뿐 아니라 상안정성(phase stability) 유지를 위하여 산화안정성이 높은 적절한 부형제가 선택되어야만 한다. 가장 바람직한 부형제로는 탈지분유(skim milk) 또는 대두분리단백을 들 수 있다.In addition, according to the present invention, in the preparation of low calorie mayonnaise, MC should be selected from a suitable excipient with high oxidation stability to maintain phase stability as well as to maintain shape retention at various storage and distribution temperatures. Most preferred excipients include skim milk or soybean isolate.

본 발명에 따르면 유산균 동결건조 과정에서 유산균 세포의 생존율(viability)을 높힘과 동시에 상안정성을 유지하기 위한 가장 바람직한 부형제는 상기 탈지분유 또는 대두분리단백 중에서 선택되어야 한다.According to the present invention, the most preferred excipient for increasing the viability of the lactic acid bacteria cells while maintaining the stability of the lactic acid bacteria in the lyophilization process should be selected from the skim milk powder or soybean separation protein.

상기 두 가지 부형제(expients)는 본 발명 마요네즈 조성물의 재지방성분이 되는 식물성 식용유로서 옥배유, 대두유, 올리브유 등의 효과적인 유화에 도움을 줄 수 있고 동시에 점도(pcs) 저하를 억제함으로써 마요네즈의 상안정성 유지에 매우 효과적이다.The two excipients (veients) as a vegetable cooking oil which is a red fat component of the mayonnaise composition of the present invention can help effective emulsification of jade oil, soybean oil, olive oil, etc. and at the same time maintain the phase stability of mayonnaise Very effective at

탈지분유(skim milk)는 우유에서 지방을 분리제거하고 건조한 분말로서 증점력, 결탁력, 유화력이 우수하다. 또 분리대두단백(sp)은 대두에서 분리한 단백질로 총전하값이 0이 되는 pH 즉 등전점(PI)에 따라 용해도가 상이한데 대체로 pH 4.0~5.6에서 뛰어난 유화력과 수화력이 유지된다.Skim milk is a dry powder that separates and removes fat from milk and has excellent thickening, cohesion, and emulsifying power. In addition, soy protein (sp) is a protein isolated from soybean, and its solubility varies depending on the pH at which the total charge value becomes zero, that is, the isoelectric point (PI). Generally, excellent emulsification and hydration is maintained at pH 4.0 to 5.6.

본 발명에 따르면 마요네즈는 pH4.5~pH5.5 수준의 산성식품이므로 7S(pH4.0~5.6)를 사용하는 경우 겔형성능과 우수한 점도 1.27 x 105 cp를 얻을수 있으므로 유용하게 사용될 수 있다.According to the present invention, mayonnaise is an acidic food having a pH of 4.5 to pH 5.5. Thus, when 7S (pH 4.0 to 5.6) is used, gel formation ability and excellent viscosity of 1.27 x 10 5 cp can be obtained.

본 발명 바람직한 저열량의 정장기능성 마요네즈를 제조하기 위하여 바람직한 첨가제로서 식초, 소금, 설탕이 포함된다.The present invention includes vinegar, salt, and sugar as a preferred additive to prepare a low calorie-retaining functional mayonnaise.

본 발명에 따르면 저열량 정장기능성 마요네즈 조성물을 얻기 위하여 상기 유산균 포접제 외에도 필요한 경우 마요네즈의 부드러운 촉감을 증진시키기 위해 상안정제로 HPMC를 장용성기재로 사용하는 경우 젤라틴(gelatin) 또는 산탄검(xanthan gum)이 마요네즈 총중량의 1중량% 이내 범위에서 추가로 더 포함될 수 있다. 상기 젤라틴이나 산탄검은 유산균의 포접시 냉각겔화법을 적용하는 경우 매우 유용하다.According to the present invention, gelatin or xanthan gum is used when HPMC is used as an enteric substrate as an upper stabilizer to enhance the soft touch of mayonnaise, if necessary, in addition to the lactic acid bacterium clathrate to obtain a low calorie formal functional mayonnaise composition. It may be further included in the range within 1% by weight of the mayonnaise gross weight. The gelatin or xanthan gum is very useful when applying the cooling gelation method of the inclusion of lactic acid bacteria.

냉각겔화법은 상온에서 겔이 형성되는 젤라틴으로 제조된 용액 또는 산탄검을 포함하는 HPMC 용액을 10~30℃에서 가열하여 제조하면 유화안정성과 점성을 증대시킬 수 있다.The cooling gelation method may increase the emulsion stability and viscosity when the HPMC solution containing xanthan gum or a solution made of gelatin that gel is formed at room temperature is heated at 10 to 30 ° C.

한편, 본 발명에 따르면, HPMC를 장용성기재로 사용하는 경우 앞서 설명한 장용성기재 HPMCP를 사용한 타정제품과 달리 유산균의 피막을 형성하는 캡슐의 피막강도를 제고하여 부드러운 씹힘성을 증진시키기 위해 가소제를 추가로 더 포함할 수 있다.On the other hand, according to the present invention, when using the HPMC as an enteric substrate, unlike the tableting product using the enteric substrate HPMCP described above, further enhances the film strength of the capsule forming the film of lactic acid bacteria to further enhance the soft chewability of the plasticizer It may include.

본 발명에서, 바람직한 수용성 가소제로는 글리세린, 환원 옥수수시럽(hydrogenated corn syrup), PEG(polyethylene glycol) 또는 PG(propylene glycol)로 이루어진 군에서 선택하여 사용될 수 있다. 상기 가소제의 첨가량은 물에 용해한 마요네즈 조성물 총량기준 0.5~1.5 중량%가 바람직하다.In the present invention, the preferred water-soluble plasticizer may be selected from the group consisting of glycerin, reduced corn syrup (hydrogenated corn syrup), PEG (polyethylene glycol) or PG (propylene glycol). The amount of the plasticizer added is preferably 0.5 to 1.5% by weight based on the total amount of mayonnaise composition dissolved in water.

상기와 같이 제조된 수성 가소제 조성물의 pH는 4.5~6.0 수준이며 점도는 상온에서 즉 15℃~20℃에서 1500~2500 cps를 유지하게 되므로 겔화과정에서 유산균의 생존율을 저하시키지 않는다. 본 발명에 따르면, 상기 유산균의 gel type 제형이 포함되는 마요네즈를 제조하는 경우에는 본 발명에서 사용하는 내산성 및 내열성 균주 P. acidlactici PAGA KCTC18229P 균주를 사용하지 않더라도 내산성인 균주로 이루어진 유산균 그룹에서 어느 것을 선택하여 사용하여도 무방하다.The pH of the aqueous plasticizer composition prepared as described above is 4.5 to 6.0 and the viscosity is maintained at 1500 ~ 2500 cps at 15 ℃ ~ 20 ℃ at room temperature, so does not reduce the survival rate of lactic acid bacteria in the gelation process. According to the present invention, when preparing mayonnaise containing the gel-type formulation of the lactic acid bacteria selected from the group of lactic acid bacteria consisting of strains that are acid-resistant and heat-resistant strain P. acidlactici PAGA KCTC18229P strain used in the present invention even if not used It may be used.

본 발명에 따르면 상기 유산균 중에서 선택된 Probiotics가 포접된 gel-type probiotics가 첨가된 씹힘성이 적거나 전혀 없는 mild 또는 soft type의 저열량 정장기능성 마요네즈를 제조하기 위하여 상기 유산균의 첨가량은 마요네즈 조성물 총중량에 대하여 1~2 중량% 포함하는 것이 실험결과 가장 바람직하다.According to the present invention, the amount of lactic acid bacteria added to the total weight of mayonnaise composition in order to prepare a mild or soft low-calorie caloric functional mayonnaise with little or no chew added to the gel-type probiotics containing the selected probiotics among the lactic acid bacteria It is most preferable to include 2% by weight.

이는 앞의 내산성, 내열성 유산균이 포접된 씸힘성이 있는 hard type의 tablet probiotics가 첨가된 저열량 정장기능성 마요네즈를 제조하기 위하여 마요네즈 조성물 총중량에 대하여 1~2 중량% 포함시키는 것과 차이가 없다.This is not different from including 1-2% by weight of the mayonnaise composition in order to prepare a low-calorie formal functional mayonnaise added to the hard type tablet probiotics containing the acid-resistant, heat-resistant lactic acid bacteria.

본 발명의 hard-type, mild type 및 soft type 저열량 정장기능성 마요네즈의 재료성분과 함량은 하기 표 1, 표 2 및 표3과 같다.The material components and contents of the hard-type, mild type and soft type low calorie formal functional mayonnaise of the present invention are shown in Tables 1, 2 and 3 below.

재료
(중량%)
material
(weight%)
실시예Example 비교예1
Comparative Example 1
비교예2
Comparative Example 2
1One 22 33 44 계란
(난황)
egg
(Warm yolk)
1515 1515 1212 1212 1212 1515
올리브유olive oil 2525 2525 3030 3030 7070 8080 MC(10% 수용액)MC (10% aqueous solution) 2020 2020 2020 2020 -- -- 식초vinegar 22 22 22 22 22 22 소금Salt 1One 1One 1One 1One 1One 1One 설탕Sugar 22 22 22 22 22 22 HPMCPHPMCP 1One 22 22 1One -- -- 유산균
(P. acidlactici)
Lactobacillus
(P. acidlactici)
1One 22 22 1One -- --
탈지분유Skim milk powder 88 1010 1010 88 -- -- 정제수Purified water 잔량Remaining amount 잔량Remaining amount 잔량Remaining amount 잔량Remaining amount 잔량Remaining amount 잔량Remaining amount 합계Sum 100100 100100 100100 100100 100100 100100

재료
(중량%)
material
(weight%)
실시예Example 비교예1
Comparative Example 1
비교예2
Comparative Example 2
55 66 77 88 계란
(난황)
egg
(Warm yolk)
1515 1515 1212 1212 1212 1515
올리브유olive oil 2525 2525 3030 3030 7070 8080 MC(10% 수용액)MC (10% aqueous solution) 2020 2020 2020 2020 -- -- 식초vinegar 22 22 22 22 22 22 소금Salt 1One 1One 1One 1One 1One 1One 설탕Sugar 22 22 22 22 22 22 HPMCPHPMCP 1One 22 22 1One -- -- 유산균
(P. acidlactici)
Lactobacillus
(P. acidlactici)
0.50.5 1One 1One 0.50.5 -- --
유산균
(L. fermentum)
Lactobacillus
(L. fermentum)
0.50.5 1One 1One 0.50.5 -- --
gelatingelatin 33 44 44 33 -- -- 탈지분유Skim milk powder 88 1010 1010 88 -- -- 정제수Purified water 잔량Remaining amount 잔량Remaining amount 잔량Remaining amount 잔량Remaining amount 잔량Remaining amount 잔량Remaining amount 합계Sum 100100 100100 100100 100100 100100 100100

재료
(중량%)
material
(weight%)
실시예Example 비교예1
Comparative Example 1
비교예2
Comparative Example 2
99 1010 1111 1212 계란
(난황)
egg
(Warm yolk)
1515 1515 1212 1212 1212 1515
올리브유olive oil 2525 2525 3030 3030 7070 8080 HPMC(5% 수용액)HPMC (5% aqueous solution) 2020 2020 2020 2020 -- -- 산탄검Xanthan Gum 1One 1One 1One 1One -- -- PGPG 1One 1One 1One 1One -- -- 식초vinegar 22 22 22 22 22 22 소금Salt 1One 1One 1One 1One 1One 1One 설탕Sugar 22 22 22 22 22 22 HPMCPHPMCP 1One 22 22 1One -- -- 유산균
(P. acidlactici)
Lactobacillus
(P. acidlactici)
1One 22 22 1One -- --
탈지분유Skim milk powder 88 1010 1010 88 -- -- 정제수Purified water 잔량Remaining amount 잔량Remaining amount 잔량Remaining amount 잔량Remaining amount 잔량Remaining amount 잔량Remaining amount 합계Sum 100100 100100 100100 100100 100100 100100

이상 설명한 바와 같이 본 발명은 유산균주의 포접물에 의하여 하드-타입의 씹힘성이 우수한 정장기능성 마요네즈를 제공하는 효과가 있으며 첨가된 오일함량이 저감되면서도 상안정성과 점도가 우수한 저열량의 정장기능성 마요네즈를 제공하는 뛰어난 효과가 있다. As described above, the present invention has an effect of providing a formal functional mayonnaise having excellent hard-type chewability by clathrates of lactic acid strains, and provides a low calorie functional functional mayonnaise having superior phase stability and viscosity while reducing the added oil content. Excellent effect.

도 1은 본 발명 마요네즈의 재료성분과 구성과 그 제조방법에 대한 모식도이다. 1 is a schematic view of the material composition and configuration of the mayonnaise of the present invention and a method of manufacturing the same.

실시예 1Example 1

상기 표 1 내지 3에 제시된 재료성분과 함량으로 저열량 hard type 마요네즈를 제조하기 위하여 올리브유 첨가량을 획기적으로 줄이고 그대신 MC(methyl cellulose) 10% 수용액을 첨가하여 미리 skim-milk로 동결건조시킨 유산균과 HPMCP를 중량비 1:1(w/w)로 혼합하여 2~3 mm size 크기로 타정한 유산균 tablet을 첨가하여 정장기능성 하드 타입 마요네즈를 제조하였다.In order to prepare low calorie hard type mayonnaise with the ingredients and contents shown in Tables 1 to 3, the amount of olive oil is drastically reduced, and lactic acid bacteria and HPMCP previously lyophilized with skim-milk by adding MC (methyl cellulose) 10% aqueous solution. To prepare a functional hard type mayonnaise by mixing the weight ratio of 1: 1 (w / w) by adding a tablet of lactic acid bacteria tableted to a size of 2 ~ 3 mm size.

여기서, 비교예 1 및 2는 종래의 시중에서 판매중인 마요네즈 제품이다. Here, Comparative Examples 1 and 2 are conventional mayonnaise products sold on the market.

먼저, 유산균 생균제 타블렛은 P. acidlactici GS 균주를 skim-milk를 첨가하여 통상의 방법으로 동결건조시킨 것을 HPMCP 분말과 동량의 증량비(1:1)로 배합하여 실온에서 제약용 타정기를 사용하여 2~3 mm 사이즈, 총질량 15 mg(유산균 7.5 mg: HPMCP 7.5 mg)이며 타정강도 3~6 KP(kilo pound)의 테블렛 제품을 제조하였다.First, lactic acid bacteria probiotic tablets were prepared by lyophilizing P. acidlactici GS strain with skim-milk in a conventional manner in the same amount (1: 1) with HPMCP powder and using a tablet press at room temperature. Tablet products of a size of 3 mm, a total mass of 15 mg (lactic acid bacteria 7.5 mg: HPMCP 7.5 mg) and a tableting strength of 3-6 KP (kilo pound) were prepared.

또, 표 2 및 표 3에 제시된 재료성분과 함량으로 저열량 mild- 또는 soft type 마요네즈를 제조하였다.In addition, low calorie mild- or soft type mayonnaise was prepared using the ingredients and contents shown in Tables 2 and 3.

mild-type 마요네즈는 HPMCP로 타정한 내산성 소형구균의 유산균 외에도 내산성이 아닌 L. fermentum 등 유산균주를 추가하여 더 사용하고 유산균 포접시 냉각겔화법을 적용하였다. 대체로 상기 유산균주의 첨가량은 중량비로 1:1(w/w)이 바람직하다. 한편, soft-type 마요네즈는 반드시 내산성인 소형구균 유산균주 P. acidlactici 균주를 탈지분유로 동결건조시킨 powder와 HPMC 5%수용액에 가소재로서 프로필렌 글리콜(PG)을 첨가하여 수성조성물을 제조하여 사용한다. Mild-type mayonnaise was added by adding lactic acid bacteria such as L. fermentum, which was not acid resistant, in addition to lactic acid bacteria of acid-resistant micrococci compressed into HPMCP. In general, the amount of the lactic acid strain added is preferably 1: 1 (w / w) by weight. On the other hand, soft-type mayonnaise must be prepared by adding propylene glycol (PG) as a plastic material to powder and HPMC 5% aqueous solution, which is freeze-dried with S. coli lactobacillus strain P. acidlactici, which is acid resistant. .

상기 가소제는 유산균의 피막캡슐의 강도를 높히는데 이때 씹힘성을 증진시키게 되며 바람직한 가소제의 첨가향은 마요네즈 조성물 총량 기준 1 중량%를 사용하였다. The plasticizer increases the strength of the film capsule of the lactic acid bacteria to improve the chewiness and the preferred addition of the plasticizer was used 1% by weight of the total amount of mayonnaise composition.

이하 본 발명의 구현예로서 상기 표 1에 따라 내산성 첨가제 HPMCP 55(hydroxypropyl methylcellulose phthalate)를 사용하여 탈지분유로 동결건조한 내산성 유산균 P. acidlactici biotics를 동량의 중량비(w/w)로 배합하여 실온에서 제약용 타정기를 사용하여 직경 2 mm이고 총질량 25mg(유산균 7.5 mg): HPMCP 12.5mg)이며 타정시 경도 3~6 KP의 생균제 tablet을 제조하였다.According to the embodiment of the present invention, the acid-resistant lactic acid bacteria P. acidlactici biotics lyophilized with skim milk powder using an acid-resistant additive HPMCP 55 (hydroxypropyl methylcellulose phthalate) according to Table 1 is formulated at the same weight ratio (w / w) to be pharmaceutical at room temperature. Using a tableting machine, a probiotic tablet having a diameter of 2 mm and a total mass of 25 mg (lactic acid bacteria 7.5 mg): HPMCP 12.5 mg) and a hardness of 3 to 6 KP was prepared during tableting.

제조된 생균제 tablet을 실시예 1 내지 4의 마요네즈 배합비(w)에 따라 제조하였다.Prepared probiotic tablet was prepared according to the mayonnaise blending ratio (w) of Examples 1 to 4.

먼저 상안정도와 시중 최적점도 1.27 x 105cp(p>0.05)를 유지하기 위하여 중화제 MC(methyl cellulose)를 정제수에 혼합하여 8,000 rpm에서 5분간 교반하여 10% 수용액으로 수화시키고 여기에 계란난황을 첨가하고 같은 조건으로 교반하여 재수화시켰다. 다음에 올리브유를 서서히 첨가하면서 8,000 rpm에서 3분간 더 교반하여 수중유적형(O/W) 상태로 만들었다. 이어서, 설탕, 소금 및 유화안정제(필요시, 마요네즈 조성물 총 중량의 가장 바람직하게는 산탄검을 0.5 중량부 이하)를 함께 첨가하고 같은 속도로 1분간 더 mix한 후 마지막으로 상기에서 제조된 내산성 및 내열성 유산균 P. acidlactici tablet과 식초를 첨가하여 30 sec 이내로 혼합하여 균질화하였다.First, in order to maintain the stability and optimum viscosity of 1.27 x 10 5 cp (p> 0.05), the neutralizing agent MC (methyl cellulose) was mixed with purified water, stirred at 8,000 rpm for 5 minutes, hydrated in a 10% aqueous solution, and egg yolk was added thereto. It was added and stirred to the same conditions to rehydrate. Next, olive oil was slowly added, followed by further stirring at 8,000 rpm for 3 minutes to bring an oil-in-water (O / W) state. Then, sugar, salt and emulsifying stabilizer (if necessary, most preferably 0.5 parts by weight of xanthan gum of the total weight of the mayonnaise composition) are added together and mixed for another minute at the same rate, and finally the acid and heat resistances prepared above. Lactic acid bacteria P. acidlactici tablet and vinegar were added and mixed within 30 sec and homogenized.

이 때, wild type 또는 soft type 제형을 위해 상안정제로서 gelatin 또는 산탄검과 PG를 추가로 더 첨가하였다.At this time, gelatin or xanthan gum and PG were further added as a stabilizing agent for the wild type or soft type formulation.

상기 실시예 1~4에 따라 제조된 마요네즈의 유화 안정성과 저장기간별 점도, 내열성, 내산성, 내동성 및 관능검사를 수행하였다.The emulsification stability of the mayonnaise prepared according to Examples 1 to 4 and storage viscosity, heat resistance, acid resistance, dynamic resistance and sensory test were performed.

실험예Experimental Example 1. 유화 안정성 (Emulsion stability) 1.Emulsion stability

실시예Example 1One 22 33 44 비교예 1Comparative Example 1 비교예 2Comparative Example 2 (%)
FI/FO
100
(%)
FI / FO
100
94.294.2 96.896.8 95.895.8 95.595.5 93.593.5 94.294.2

실험결과, 본 발명의 실시예1 내지 4에 기재된 하드타입 마요네즈 조성물의 유화안정성은 통상의 시중제품보다 못지 않은 우수성이 입증되었다(표 4).As a result, the emulsification stability of the hard type mayonnaise composition described in Examples 1 to 4 of the present invention was demonstrated to be superior to that of ordinary commercial products (Table 4).

실험예Experimental Example 2. 저장기간별 점도측정(CPS) 2. Viscosity Measurement by Storage Period (CPS)

실시예Example 1주1 week 2주2 weeks 3주3 weeks 4주4 Weeks 1One 1.22x 105 1.22 x 10 5 1.20x 105 1.20 x 10 5 1.18x 105 1.18 x 10 5 1.16x 105 1.16 x 10 5 22 1.26x 105 1.26 x 10 5 1.26x 105 1.26 x 10 5 1.25x 105 1.25 x 10 5 1.24x 105 1.24 x 10 5 33 1.25x 105 1.25 x 10 5 1.24x 105 1.24 x 10 5 1.20x 105 1.20 x 10 5 1.18x 105 1.18 x 10 5 44 1.23x 105 1.23 x 10 5 1.22x 105 1.22 x 10 5 1.20x 105 1.20 x 10 5 1.20x 105 1.20 x 10 5 비교예 1Comparative Example 1 0.92x 105 0.92 x 10 5 0.90x 105 0.90 x 10 5 0.76x 105 0.76 x 10 5 0.58x 105 0.58 x 10 5 비교예 2Comparative Example 2 0.87x 105 0.87 x 10 5 0.88x 105 0.88 x 10 5 0.84x 105 0.84 x 10 5 0.64x 105 0.64 x 10 5

실험결과, 본 발명 하드타입 마요네즈는 시중판매되는 마요네즈의 점도 1.22x 105 CP와 차이가 나타나지 않았다(표 5).As a result of the experiment, the hard type mayonnaise of the present invention did not show a difference from the viscosity of commercially available mayonnaise 1.22 × 10 5 CP (Table 5).

실험예 3. 내열성 측정Experimental Example 3. Measurement of heat resistance

본 발명 실시예 1 내지 4의 하드타입 마요네즈의 내열성을 측정하기 위해 마요네즈용 튜브를 사용하여 5g 수준 특유의 형상을 유지하도록 덜어내 50℃ 에서 30분, 100℃에서 30분간 10분 단위로 보형성 및 유분리 정도의 실험을 수행한 결과는 다음 표 6과 같았다.In order to measure the heat resistance of the hard-type mayonnaise of Examples 1 to 4 of the present invention using a mayonnaise tube to remove the shape to maintain a unique shape of 5g level to form a 30 minutes at 50 ℃, 30 minutes at 100 ℃ 30 minutes And the results of the experiment of the degree of oil separation were as shown in Table 6.

구분
division
성상Constellation 실시예 1Example 1 실시예 2Example 2 실시예 3Example 3 실시예 4Example 4 비교예 1Comparative Example 1 비교예 2Comparative Example 2
50℃50 ℃ 10분10 minutes 보형성Prosthesis 유분리Oil separation -- -- -- -- -- -- 20분20 minutes 보형성Prosthesis 유분리Oil separation -- -- -- -- ++ ++ 30분30 minutes 보형성Prosthesis 유분리Oil separation -- -- -- -- ++ ++++ 100℃100 ℃ 10분10 minutes 보형성Prosthesis 유분리Oil separation -- -- -- -- ++ ++++ 20분20 minutes 보형성Prosthesis xx 유분리Oil separation ++ ++ ++ ++ ++++ ++++++ 30분30 minutes 보형성Prosthesis xx xx 유분리Oil separation ++ ++++ ++ ++++ ++++++ ++++++ [주] 보형성: ○ 처음상태유지, △ 표면 유분리, □ 유분리 확인, x 완전 유분리
유분리 여부: - 없음, + 유분리 관찰, ++ 매우 불량
[Formula] Formation: ○ Maintaining initial state, △ Surface oil separation, □ Oil separation confirmation, x Complete oil separation
Oil separation:-none, + oil separation observed, ++ very poor

실험예 4. 내산성 실험Experimental Example 4. Acid Resistance Test

본 발명 실시예1 내지 4의 하드 타입 마요네즈를 위장관 환경(SGF)에서 2시간, 소장관 환경(SIF)에서 4시간 동안 37℃, 50 rpm에서 진탕처리하여 1시간 단위로 sampling하여 MRS agar plate에 도말하여 37℃에서 24 시간 배양한 후 생균수(cfu)를 측정한 결과 유산균 생균의 생존율(viability)은 위장 환경에서는 실시예 1 내지 4에서 75~90%가 생존하였고 소장 환경에서는 그대로 6시간이상 안정적으로 유지되었음이 확인되었다.The hard type mayonnaise of Examples 1 to 4 of the present invention was shaken at 37 ° C. and 50 rpm for 2 hours in the gastrointestinal tract (SGF) and 4 hours in the small intestinal tract (SIF). After vibrating at 37 ° C for 24 hours and measuring the number of viable cells (cfu), the viability of lactic acid bacteria was 75 ~ 90% in Examples 1 to 4 in the gastrointestinal environment and 6 hours or more in the small intestine environment. It was confirmed that it remained stable.

실험예 5. 내동성 실험Experimental Example 5. Dynamic Resistance Test

본 발명 실시예1 내지 4의 하드타입 마요네즈를 50mL 원심분리관에 25g씩 칭량하고 -13℃에서 36시간 냉동저장한 후 완전해동하여 성상 및 유분리 정도를 관찰한 결과는 초기상태를 유지하고 유분리현상은 발견되지 않았다.The hard type mayonnaise of Examples 1 to 4 was weighed 25g in a 50mL centrifuge tube and frozen for 36 hours at -13 ° C, and then thawed completely. No separation was found.

실험예 6. 관능검사Experimental Example 6. Sensory Test

본 발명 실시예1 내지 4의 하드타입 마요네즈를 남여 각각 5명씩 random sampling 하여 전문 panel 10명에게 시식시킨후 5점 척도법으로 관능검사를 실시하고 그 평균값을 구한 결과는 다음 표 7에 나타냈다.The hard type mayonnaise of Examples 1 to 4 of the present invention was randomly sampled by five men and 10, and then sampled by 10 professional panelists. The sensory test was performed by a five-point scale method, and the average values thereof are shown in Table 7 below.

실시예Example 1One 22 33 44 비교예 1Comparative Example 1 비교예 2Comparative Example 2 외관Exterior 4.54.5 4.64.6 4.54.5 4.44.4 3.53.5 3.43.4 풍미zest 4.64.6 4.34.3 4.24.2 4.74.7 3.63.6 3.33.3 질감Texture 4.44.4 4.54.5 4.54.5 4.64.6 2.92.9 2.82.8 점성viscosity 4.54.5 4.74.7 4.64.6 4.54.5 3.53.5 3.73.7 종합기호도General Symbol 4.54.5 4.74.7 4.54.5 4.64.6 3.83.8 3.93.9

Claims (2)

올리브유 25~30 중량%, MC 또는 HPMC 수용액 20 중량%, 계란 난황 12~15 중량%를 주재로 하고 HPMC와 동결건조한 P. acidlactici 유산균이 함유된 것이 특징인 하드 타이프 저열량 정장기능성 마요네즈 조성물.
Hard type low calorie low-molecular functional mayonnaise composition characterized by containing 25-30% by weight of olive oil, 20% by weight of MC or HPMC aqueous solution, 12-15% by weight of egg yolk, and containing HPMC and lyophilized P. acidlactici lactic acid.
제1항의 마요네즈 조성물로 제조된 씹힘성이 우수한 하드 타입 저열량 정장기능성 마요네즈.
Hard type low calorie dressing functional mayonnaise excellent in chewability made with the mayonnaise composition of claim 1.
KR1020180022879A 2018-02-26 2018-02-26 Hard-type Low calory Mayonnaise conposition for Intestinal regulation comprising lactic acid bacteria and preparation method thereof KR102417609B1 (en)

Priority Applications (2)

Application Number Priority Date Filing Date Title
KR1020180022879A KR102417609B1 (en) 2018-02-26 2018-02-26 Hard-type Low calory Mayonnaise conposition for Intestinal regulation comprising lactic acid bacteria and preparation method thereof
PCT/KR2018/002453 WO2019164043A1 (en) 2018-02-26 2018-02-28 Intestine regulating, low-calorie, hard-type mayonnaise containing lactic acid bacteria and manufacturing method therefor

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
KR1020180022879A KR102417609B1 (en) 2018-02-26 2018-02-26 Hard-type Low calory Mayonnaise conposition for Intestinal regulation comprising lactic acid bacteria and preparation method thereof

Publications (2)

Publication Number Publication Date
KR20190102463A true KR20190102463A (en) 2019-09-04
KR102417609B1 KR102417609B1 (en) 2022-08-05

Family

ID=67688162

Family Applications (1)

Application Number Title Priority Date Filing Date
KR1020180022879A KR102417609B1 (en) 2018-02-26 2018-02-26 Hard-type Low calory Mayonnaise conposition for Intestinal regulation comprising lactic acid bacteria and preparation method thereof

Country Status (2)

Country Link
KR (1) KR102417609B1 (en)
WO (1) WO2019164043A1 (en)

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP3227495B2 (en) * 1997-07-03 2001-11-12 盛田株式会社 Raw mayonnaise and method for producing the same
JP2005198576A (en) * 2004-01-16 2005-07-28 Asahi Denka Kogyo Kk Molded product for food
KR20130049763A (en) * 2011-11-04 2013-05-14 삼성정밀화학 주식회사 Low-fat mayonnaise composition and method manufacturing thereof

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NZ239858A (en) * 1990-09-25 1994-08-26 Cpc International Inc No fat or low fat mayonnaise product including microcrystalline cellulose,polydextrose and egg white
KR20020063978A (en) * 2001-01-31 2002-08-07 전홍렬 Lactic acid bacteria-containing microgranular composition for enteric delivery and process for the preparation thereof
WO2003096823A1 (en) * 2002-05-17 2003-11-27 Unilever N.V. Edible emulsion comprising live micro-organisms
KR100578078B1 (en) * 2004-06-30 2006-05-10 현대삼호중공업 주식회사 Jack-up type wheel turning system and method for gantry crane
KR101473421B1 (en) * 2013-02-28 2014-12-19 충청대학 산학협력단 Composition for improving irritable bowel syndrome

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP3227495B2 (en) * 1997-07-03 2001-11-12 盛田株式会社 Raw mayonnaise and method for producing the same
JP2005198576A (en) * 2004-01-16 2005-07-28 Asahi Denka Kogyo Kk Molded product for food
KR20130049763A (en) * 2011-11-04 2013-05-14 삼성정밀화학 주식회사 Low-fat mayonnaise composition and method manufacturing thereof

Also Published As

Publication number Publication date
WO2019164043A1 (en) 2019-08-29
KR102417609B1 (en) 2022-08-05

Similar Documents

Publication Publication Date Title
JP6150353B2 (en) Treatment of IBD and IBS using probiotic bacteria and fermented cereal as therapeutic effectors
EP2477638B1 (en) Probiotic stabilization
EP1458247B1 (en) Malleable protein matrix and uses thereof
KR101564985B1 (en) Novel application of reduced-fat soybean protein material to soybean-derived raw material-containing food or beverage
CN103623010A (en) Probiotics in a pre- and/or post-surgical environment
JP2011246483A (en) Endotoxin binding by lactic acid bacteria and bifidobacteria
PT1010372E (en) Bakery products comprising live lyophilised lactic bacteria
NZ550501A (en) Use of a fermentation product of propionic acid bacterium for treating inflammatory bowel diseases
CN105941627A (en) Symbiotic and nutritional yoghurt freeze-dried tablets and preparation method thereof
CN106923345B (en) Stabilized probiotic compositions
Ahmad et al. Therapeutic aspects of probiotics and prebiotics
JP6823302B2 (en) Anti-allergic agent for babies
KR101707551B1 (en) Method for Preparing Chocolates Containing Viable Preparations of Lactic Acid Bacteria
KR102417611B1 (en) Mild-, soft type Low calory Mayonnaise conposition for Intestinal regulation comprising lactic acid bacteria and preparation method thereof
CN116867891A (en) Microencapsulated microbial culture formulations with high storage stability
JP2003306436A (en) Inhibitor of increased serum cholesterol level
JP2004051530A (en) Intestinal flora-improving agent and food or drink containing the same
KR102417609B1 (en) Hard-type Low calory Mayonnaise conposition for Intestinal regulation comprising lactic acid bacteria and preparation method thereof
JPH04364123A (en) Coating material and enteric granule produced by using the same
JP3202053B2 (en) Enteric granules
CN106974940B (en) Application of probiotics of scleritis in treating and preventing obesity and related diseases
WO2019157430A1 (en) Matricial microencapsulation compositions
Balance Probiotic 100 100 Billion CFU Advanced Probiotic

Legal Events

Date Code Title Description
E902 Notification of reason for refusal
E701 Decision to grant or registration of patent right